Investors

Stock Information

Quantumzyme Corp. has developed a catalyst for generating Ibuprofen APIs for the Pharma Industry. At this time, our intellectual property is protected by trade secret laws, and we expect to shortly begin the process of filing patent applications to secure our intellectual property.

We are a biotransformation company, focused on clean and green chemistry. We utilize customer centric research to enhance enzyme activity, selectivity and specificity by applying novel quantum mechanics, molecular modeling and engineering approaches. The uniqueness of our IP lies in its advanced framework that offers distinct solutions for specific bio-catalysis requirements.

Our goal is to help to foster a clean, healthy and well protected environment supporting a sustainable society and economy. Ultimately, we want to fulfill our vision by developing a focused approach to aid all chemical companies to harness the power of technology by simplifying complex chemistry and reducing the number of steps by implementing scientific rationale like quantum mechanics in biology. We intend to license our IP as a technology to major API manufacturers and Pharma companies.

With large scale manufacturing of Ibuprofen API and use of said APIs in manufacturing of drugs by Pharma Companies, we intend to generate revenue from the technology cost and through royalties.